Education
About Us
Working with TipRanks
Follow Us
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
| Dec 18 | Dec 17 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ -157.00K | $ -120.00K |
| Operating Income | $ -76.50M | $ -48.57M |
| EBITDA | $ -76.34M | $ -48.45M |
| Net Income | $ -73.31M | $ -50.55M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 48.53M | $ 74.47M |
| Total Assets | $ 107.31M | $ 136.85M |
| Total Debt | $ 30.13M | $ 0.00 |
| Net Debt | $ -18.40M | $ -74.47M |
| Total Liabilities | $ 80.72M | $ 45.65M |
| Stockholders' Equity | $ 159.37M | $ 85.90M |
| Cash Flow | ||
| Free Cash Flow | $ -61.73M | $ -41.36M |
| Operating Cash Flow | $ -61.69M | $ -41.08M |
| Investing Cash Flow | $ -39.00K | $ -266.00K |
| Financing Cash Flow | $ 35.96M | $ 106.78M |
Sienna Biopharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.